David Hering - 01 Sep 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Executive Officer, Director
Signature
/s/ Jill Andersen attorney-in-fact for David Hering
Issuer symbol
IVVD
Transactions as of
01 Sep 2022
Net transactions value
+$36,160
Form type
4
Filing time
01 Sep 2022, 16:28:39 UTC
Previous filing
06 Jul 2022
Next filing
16 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IVVD Common Stock Purchase $36,160 +8,000 $4.52 8,000 01 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $4.515 to $4.52. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.